Understanding how different types of eosinophil cell death affect health
Pathophysiological impact of subtypes of eosinophil cell death
This study is looking at how a type of white blood cell called eosinophils affects conditions like asthma and heart disease, to help us understand how they can sometimes help our bodies and other times cause problems.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Cincinnati NIH-funded |
| Lab location | 1 site (Cincinnati, United States) |
| Project ID | NIH-10825101 on NIH RePORTER |
What this research studies
This research investigates the role of eosinophils, a type of white blood cell, in various immune diseases, particularly focusing on their involvement in conditions like asthma and eosinophilic heart disease. The study aims to understand how different mechanisms of eosinophil cell death, including a process called cytolysis, influence tissue health and disease progression. By using mouse models, researchers will explore how the release of eosinophil contents affects heart cells and overall immune responses. This could provide insights into how eosinophils can be both protective and harmful in different contexts.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from eosinophilic-associated diseases, particularly those with asthma or eosinophilic heart disease.
Not a fit: Patients with conditions unrelated to eosinophilic diseases or those who do not have elevated eosinophil levels may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments for conditions associated with eosinophils, improving patient outcomes in diseases like asthma and eosinophilic heart disease.
How similar studies have performed: Previous research has shown that understanding the mechanisms of cell death in immune cells can lead to significant advancements in treatment strategies, indicating potential success for this approach.
Where this research is happening
Cincinnati, United States
- University of Cincinnati — Cincinnati, United States (Active)
Researchers
- Principal investigator: Osuji, Immaculeta Kasarachi — University of Cincinnati
- Study coordinator: Osuji, Immaculeta Kasarachi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.